Michael Brändle

9.2k citations
117 papers · 5.1k · 2 hit papers · h-index 29

Impact in

    • Diabetes Treatment and Management
    • Diabetes Management and Research
    • Diabetes, Cardiovascular Risks, and Lipoproteins
    • Diabetes Management and Education
    • Pituitary Gland Disorders and Treatments
  • Nephrology top 2%

Papers in

    • Diabetes Treatment and Management 11
    • Pituitary Gland Disorders and Treatments 10
    • Diabetes Management and Research 10
    • Thyroid Disorders and Treatments 6
    • Adrenal and Paraganglionic Tumors 6
    • Lipoproteins and Cardiovascular Health 5

Michael Brändle

106 papers receiving 4.8k citations

Michael Brändle's Hit Papers

Liraglutide, a once‐daily human GLP‐1 analogue, added to a sulphonylurea over 26 weeks produces greater improvements in glycaemic and weight control compared with adding rosiglitazone or placebo in subjects with Type 2 diabetes (LEAD‐1 SU) 2009 · 691 citations
6910+7+14Years since publication200400600

Peers

Michael Brändle
Comparison fields: 5 of 128
  • Endocrinology, Diabetes and Metabolism 2.1k
  • Nephrology 335
  • Epidemiology 736
  • Pharmacy 100
  • Physiology 490
Replace Danita D. Byrd-Holt with:
Danita D. Byrd-Holt United States
Rachel Pessah‐Pollack United States
Michael Doumas Greece
Om P. Ganda United States
Helen C. Looker United States
Rachel H. Mackey United States
Jerzy Chudek Poland
Marguerite J. McNeely United States
Michael J. Nissen Switzerland
Altan Onat Türkiye
Michael Brändle relative to Danita D. Byrd-Holt United States Danita D. Byrd-Holt's profile →
Citations per field
00.5×6.3×
Danita D. Byrd-Holt · 1×
Citations per year

Countries citing papers authored by Michael Brändle

Since Specialization
Citations

This map shows the geographic impact of Michael Brändle's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael Brändle with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael Brändle more than expected).

Fields of papers citing papers by Michael Brändle

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael Brändle. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael Brändle. The network helps show where Michael Brändle may publish in the future.

Co-authors

The 25 scholars most cited alongside Michael Brändle, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Michael Brändle Line = papers co-authored together Michael Brändle links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 117 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Liraglutide, a once‐daily human GLP‐1 analogue, added to a sulphonylurea over 26 weeks produces greater improvements in glycaemic and weight control compared with adding rosiglitazone or placebo in subjects with Type 2 diabetes (LEAD‐1 SU)
Hit paper breakdown →
2009691
2
The Cost-Effectiveness of Lifestyle Modification or Metformin in Preventing Type 2 Diabetes in Adults with Impaired Glucose Tolerance
Hit paper breakdown →
2005503
3 2002323
4 2003290
5 2003283
6 2003214
7 2009198
8 2014174
9 2020167
10 2018150
11 2013137
12 2011133
13 2004131
14 2008128
15 2010108
16 200594
17 200468
18 200757
19 201250
20 200146

About Michael Brändle

Michael Brändle is a scholar working on Endocrinology, Diabetes and Metabolism, Surgery, Epidemiology, Pulmonary and Respiratory Medicine and Physiology, having authored 117 papers that have together received 5.1k indexed citations. Recurring topics across this work include Diabetes Treatment and Management (11 papers), Pituitary Gland Disorders and Treatments (10 papers), Diabetes Management and Research (10 papers), Neuroendocrine Tumor Research Advances (8 papers), Parathyroid Disorders and Treatments (7 papers), Adrenal and Paraganglionic Tumors (6 papers), Thyroid Disorders and Treatments (6 papers) and Lipoproteins and Cardiovascular Health (5 papers). The work is most often cited by research in Endocrinology, Diabetes and Metabolism (2.1k citations), Nephrology (335 citations), Epidemiology (736 citations), Pharmacy (100 citations) and Physiology (490 citations). Michael Brändle has collaborated with scholars based in Switzerland, United States and United Kingdom. Frequent co-authors include William H. Herman, Christoph Schmid, Michael M. Engelgau, Peter Wiesli, Ray Burke, Bahman P. Tabaei, Robert E. Ratner, Ping Zhang, Nor Azmi Kamaruddin and Stephen Colagiuri. Their work appears in journals such as Diabetes Care, Swiss Medical Weekly, Experimental and Clinical Endocrinology & Diabetes, Diabetes Research and Clinical Practice and Clinical Endocrinology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact